These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 35915262)
1. Context-dependent tumor-suppressive BMP signaling in diffuse intrinsic pontine glioma regulates stemness through epigenetic regulation of CXXC5. Sun Y; Yan K; Wang Y; Xu C; Wang D; Zhou W; Guo S; Han Y; Tang L; Shao Y; Shan S; Zhang QC; Tang Y; Zhang L; Xi Q Nat Cancer; 2022 Sep; 3(9):1105-1122. PubMed ID: 35915262 [TBL] [Abstract][Full Text] [Related]
2. Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma. Cao H; Jin M; Gao M; Zhou H; Tao YJ; Skolnick J Sci Rep; 2020 Apr; 10(1):6140. PubMed ID: 32273545 [TBL] [Abstract][Full Text] [Related]
3. Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG. Ehteda A; Simon S; Franshaw L; Giorgi FM; Liu J; Joshi S; Rouaen JRC; Pang CNI; Pandher R; Mayoh C; Tang Y; Khan A; Ung C; Tolhurst O; Kankean A; Hayden E; Lehmann R; Shen S; Gopalakrishnan A; Trebilcock P; Gurova K; Gudkov AV; Norris MD; Haber M; Vittorio O; Tsoli M; Ziegler DS Cell Rep; 2021 Apr; 35(2):108994. PubMed ID: 33852836 [TBL] [Abstract][Full Text] [Related]
4. Fimepinostat Impairs NF-κB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma. Wang D; Yan K; Yu H; Li H; Zhou W; Hong Y; Guo S; Wang Y; Xu C; Pan C; Tang Y; Liu N; Wu W; Zhang L; Xi Q Cancer Res; 2024 Feb; 84(4):598-615. PubMed ID: 38095539 [TBL] [Abstract][Full Text] [Related]
5. Signal Transduction in Diffuse Intrinsic Pontine Glioma. Duchatel RJ; Jackson ER; Alvaro F; Nixon B; Hondermarck H; Dun MD Proteomics; 2019 Nov; 19(21-22):e1800479. PubMed ID: 31328874 [TBL] [Abstract][Full Text] [Related]
6. Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma. An S; Camarillo JM; Huang TY; Li D; Morris JA; Zoltek MA; Qi J; Behbahani M; Kambhampati M; Kelleher NL; Nazarian J; Thomas PM; Saratsis AM J Exp Clin Cancer Res; 2020 Nov; 39(1):261. PubMed ID: 33239043 [TBL] [Abstract][Full Text] [Related]
7. Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201. Xin DE; Liao Y; Rao R; Ogurek S; Sengupta S; Xin M; Bayat AE; Seibel WL; Graham RT; Koschmann C; Lu QR Neuro Oncol; 2024 Apr; 26(4):735-748. PubMed ID: 38011799 [TBL] [Abstract][Full Text] [Related]
8. Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas. Koncar RF; Dey BR; Stanton AJ; Agrawal N; Wassell ML; McCarl LH; Locke AL; Sanders L; Morozova-Vaske O; Myers MI; Hamilton RL; Carcaboso AM; Kohanbash G; Hu B; Amankulor NM; Felker J; Kambhampati M; Nazarian J; Becher OJ; James CD; Hashizume R; Broniscer A; Pollack IF; Agnihotri S Cancer Res; 2019 Aug; 79(16):4026-4041. PubMed ID: 31201162 [TBL] [Abstract][Full Text] [Related]
12. Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells. Wiese M; Hamdan FH; Kubiak K; Diederichs C; Gielen GH; Nussbaumer G; Carcaboso AM; Hulleman E; Johnsen SA; Kramm CM Cell Death Dis; 2020 Aug; 11(8):673. PubMed ID: 32826850 [TBL] [Abstract][Full Text] [Related]
13. Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas. Chung C; Sweha SR; Pratt D; Tamrazi B; Panwalkar P; Banda A; Bayliss J; Hawes D; Yang F; Lee HJ; Shan M; Cieslik M; Qin T; Werner CK; Wahl DR; Lyssiotis CA; Bian Z; Shotwell JB; Yadav VN; Koschmann C; Chinnaiyan AM; Blüml S; Judkins AR; Venneti S Cancer Cell; 2020 Sep; 38(3):334-349.e9. PubMed ID: 32795401 [TBL] [Abstract][Full Text] [Related]
14. TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist. Xu C; Liu H; Pirozzi CJ; Chen LH; Greer PK; Diplas BH; Zhang L; Waitkus MS; He Y; Yan H Acta Neuropathol Commun; 2021 Nov; 9(1):178. PubMed ID: 34732238 [TBL] [Abstract][Full Text] [Related]
15. ALK2 inhibitors display beneficial effects in preclinical models of Carvalho D; Taylor KR; Olaciregui NG; Molinari V; Clarke M; Mackay A; Ruddle R; Henley A; Valenti M; Hayes A; Brandon AH; Eccles SA; Raynaud F; Boudhar A; Monje M; Popov S; Moore AS; Mora J; Cruz O; Vinci M; Brennan PE; Bullock AN; Carcaboso AM; Jones C Commun Biol; 2019; 2():156. PubMed ID: 31098401 [TBL] [Abstract][Full Text] [Related]
16. OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypes. Liao Y; Luo Z; Deng Y; Zhang F; Rao R; Wang J; Xu L; Kumar SS; Sengupta S; DeWire-Schottmiller M; Berry K; Garrett M; Fouladi M; Drissi R; Lu QR Neuro Oncol; 2021 Jul; 23(7):1183-1196. PubMed ID: 33539525 [TBL] [Abstract][Full Text] [Related]